Catching the ‘sneak thief’ of sight
Glaucoma is one of the leading causes of blindness in the United States. Some research predicts that by the year 2040 glaucoma will become the leading cause of functional blindness in the U.S. Glaucoma is a family of many different diseases that usually causes an increase in the pressure within the eye, damaging the optic nerve. When pressure inside the eye increases over time the optic nerve is damaged. Blind spots in peripheral areas of vision may occur and eventually begin to affect the central vision. Often called the “sneak thief” of sight, most forms of glaucoma do not produce symptoms until vision is already severely damaged and may take many years to do so. However, if caught early, the disease can usually be controlled and permanent vision loss can be prevented.
Intermountain Eye Centers are fully committed to state-of-the-art clinical care of patients with glaucoma. Glaucoma has become a much more complex disease as medical knowledge has advanced and individualized care for patients has become much more important. Recent research has changed many of the aspects of the diagnosis and treatment of different forms of glaucoma and the staff members at Intermountain Eye Centers are in the forefront in development and incorporation of these improvements into the management of glaucoma. We offer the latest in glaucoma diagnosis and treatment, including Selective Laser Trabeculoplasty (SLT), Minimally Invasive Glaucoma Surgery (MIGS), including iStent and canaloplasty and micropulse cyclo-ablative procedures.
Intermountain Eye Centers are currently involved in two surgical glaucoma clinical trials. One involves a MIGS-type implant that may be an improvement on trabeculectomy. The second involves implanting intraocular pressure-lowering medications in the eye as an alternative to eye drops for medical treatment of glaucoma.